Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Alan Menter

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Proceedings (Baylor University. Medical Center)|April 6, 2019
Successful treatment of atopic dermatitis with the JAK1 inhibitor oclacitinibIsabel M Haugh, Ian T Watson, M Alan Menter
Proceedings (Baylor University. Medical Center)|December 8, 2005
Diverse cutaneous manifestations associated with a single diseaseJennifer Clay Cather, Estil A Vance, M Alan Menter
Proceedings (Baylor University. Medical Center)|November 10, 2005
Psoriasiform lesions on trunk and palmsJennifer Clay Cather, John Christian Cather, M Alan Menter
Proceedings (Baylor University. Medical Center)|December 8, 2005
Meandering linear pruritic lesionJennifer Clay Cather, J Christian Cather, M Alan Menter
Journal of Drugs in Dermatology : JDD|November 9, 2012
Impact of clobetasol propionate 0.05% spray on health-related quality of life in patients with plaque psoriasisM Alan Menter, Scott W Caveney, Ronald W Gottschalk
Cutis|March 2, 2021
Erythema Ab Igne and Malignant Transformation to Squamous Cell CarcinomaElizabeth G Wilder, Jillian H Frieder, M Alan Menter
Journal of the American Academy of Dermatology|March 17, 2015
Awareness and engagement in political advocacy among dermatology residents: a needs assessmentMary E Horner, A Shadi Kourosh, M Alan Menter
Seminars in Cutaneous Medicine and Surgery|September 15, 2018
IL-17 inhibitors for psoriasisSo Yeon Paek, Jillian Frieder, Dario Kivelevitch, et al.
Proceedings (Baylor University. Medical Center)|June 16, 2018
Histiocytoid Sweet syndrome successfully treated with etanerceptIan T Watson, Isabel Haugh, Alexis R Gardner, et al.
International Journal of Dermatology|April 17, 2008
Combining systemic retinoids with biologic agents for moderate to severe psoriasisElizabeth C A Smith, Christy Riddle, M Alan Menter, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Proceedings (Baylor University. Medical Center)|April 6, 2019
Successful treatment of atopic dermatitis with the JAK1 inhibitor oclacitinibIsabel M Haugh, Ian T Watson, M Alan Menter
Proceedings (Baylor University. Medical Center)|December 8, 2005
Diverse cutaneous manifestations associated with a single diseaseJennifer Clay Cather, Estil A Vance, M Alan Menter
Proceedings (Baylor University. Medical Center)|November 10, 2005
Psoriasiform lesions on trunk and palmsJennifer Clay Cather, John Christian Cather, M Alan Menter
Proceedings (Baylor University. Medical Center)|December 8, 2005
Meandering linear pruritic lesionJennifer Clay Cather, J Christian Cather, M Alan Menter
Journal of Drugs in Dermatology : JDD|November 9, 2012
Impact of clobetasol propionate 0.05% spray on health-related quality of life in patients with plaque psoriasisM Alan Menter, Scott W Caveney, Ronald W Gottschalk
Cutis|March 2, 2021
Erythema Ab Igne and Malignant Transformation to Squamous Cell CarcinomaElizabeth G Wilder, Jillian H Frieder, M Alan Menter
Journal of the American Academy of Dermatology|March 17, 2015
Awareness and engagement in political advocacy among dermatology residents: a needs assessmentMary E Horner, A Shadi Kourosh, M Alan Menter
Seminars in Cutaneous Medicine and Surgery|September 15, 2018
IL-17 inhibitors for psoriasisSo Yeon Paek, Jillian Frieder, Dario Kivelevitch, et al.
Proceedings (Baylor University. Medical Center)|June 16, 2018
Histiocytoid Sweet syndrome successfully treated with etanerceptIan T Watson, Isabel Haugh, Alexis R Gardner, et al.
International Journal of Dermatology|April 17, 2008
Combining systemic retinoids with biologic agents for moderate to severe psoriasisElizabeth C A Smith, Christy Riddle, M Alan Menter, et al.
Pageof 4